Latiglutenase as a Treatment for Celiac Disease

Condition:   Celiac Disease Intervention:   Drug: Latiglutenase Sponsors:   Immunogenics, LLC;   National Institutes of Health (NIH);   National Center for Complementary and Integrative Health (NCCIH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials